Sie sind hier: Startseite Termine RUSSIA: Registration of Generics and Biosimilars
x
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

RUSSIA: Registration of Generics and Biosimilars

Local bioequivalence and tox studies required! Since the introduction of Federal Law 61 in 2010 for registrations of medicinal drug products in Russia, local clinical trials have been mandatory. This seminar informs you on your duties when registering a generic or biosimilar drug in Russia.
  • Local bioequivalence and tox studies required! Since the introduction of Federal Law 61 in 2010 for registrations of medicinal drug products in Russia, local clinical trials have been mandatory. This seminar informs you on your duties when registering a generic or biosimilar drug in Russia.

    Aims and objectives:

    Since the introduction of Federal Law 61 in 2010 for registrations of medicinal drug products in Russia, local clinical trials have been mandatory. This has led to an increase in local bioequivalence studies.

    On the other hand the number of drug registrations is decreasing. The hurdles for generic registration are very high and cost intensive.

    This seminar provides you with an update on the current regulatory requirements when applying for a registration (biosimilars or generics). You will be informed of your duties regarding the dossier and application process and learn in detail how to fulfill the requirements arising through the new bioequivalence guidelines.

    Topics:
    - Legal background for a generic registration
    - Current challenges in biosimilar registrations
    - Dossier and registration process
    - Local bioequivalence studies according to the new Russian guidelines

    52.52747 13.42339
Wann 30.01.2015
von 09:00 bis 17:00
Veranstaltungsort Leonardo Royal Hotel Berlin Alexanderplatz
Stadt Berlin
Kontaktname
Kontakttelefon 0621/500680
Zielgruppe This seminar addresses the needs of co-workers of the pharmaceutical industry
who intend to register generics and/or biosimilars in Russia or support the
registration process by providing the essential data.
The seminar is especially interesting for:
- clinical affairs
- medical affairs
- regulatory affairs people.
Termin übernehmen vCal
iCal

Aims and objectives:

Since the introduction of Federal Law 61 in 2010 for registrations of medicinal drug products in Russia, local clinical trials have been mandatory. This has led to an increase in local bioequivalence studies.

On the other hand the number of drug registrations is decreasing. The hurdles for generic registration are very high and cost intensive.

This seminar provides you with an update on the current regulatory requirements when applying for a registration (biosimilars or generics). You will be informed of your duties regarding the dossier and application process and learn in detail how to fulfill the requirements arising through the new bioequivalence guidelines.

Topics:
- Legal background for a generic registration
- Current challenges in biosimilar registrations
- Dossier and registration process
- Local bioequivalence studies according to the new Russian guidelines

Direktbuchung

Weitere Informationen über diesen Termin…

FORUM Institut für Management GmbH

Programm

1501234.pdf — PDF document, 267 kB (273,924 bytes)
Artikelaktionen